Clinical Trial Update: Nandrolone Decanoate in the Treatment of Telomeropathies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial of nandrolone decanoate for telomeropathies, including aplastic anemia and bone marrow failure syndromes, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Bone Marrow Failure Syndromes
• Idiopathic Pulmonary Fibrosis
• Telomere Shortening

Drugs mentioned

• Nandrolone decanoate (nandrolone decanoate)

Snippet

Sponsor: University of Sao Paulo | Conditions: Aplastic Anemia, Bone Marrow Failure Syndromes | Phase 1, Phase 2 | Status: COMPLETED